Yerace Daniel Alexander 4
4 · Coeptis Therapeutics Holdings, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Yerace Daniel Alexander
DirectorVP Operations
Transactions
- Purchase
Common Stock
2024-01-05$0.69/sh+10,850$7,486→ 1,071,455 total
Footnotes (1)
- [F1]Includes 50,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.